Abstract
The midline database was applied to search all randomized clinical trials published from 1986 to 1992 concerning the use of Nizatidine, a powerful H2-antagonist, versus other treatments, including placebo, in the treatment of duodenal ulcer disease. Therapeutic effects of nizatidine is comparable to that of other H2-antagonists; with the use of meta-analysis, no significant differences were demonstrated, both in acute and long-term treatment of duodenal ulcer between nizatidine and ranitidine, but untoward side effects were less frequent with nizatidine than with ranitidine.
| Translated title of the contribution | Nizatidine. A meta-analysis |
|---|---|
| Original language | Italian |
| Pages (from-to) | 201-207 |
| Number of pages | 7 |
| Journal | Clinica Terapeutica |
| Volume | 143 |
| Issue number | 3 |
| Publication status | Published - 1993 |
ASJC Scopus subject areas
- Medicine(all)